Business ❯ Pharmaceutical Industry

Stock Market

Company Performance Pharmaceutical Stocks Investor Sentiment Investor Reactions Market Reactions Investors Clinical Trial Results Global Markets Corporate Competition Health Stocks Company News Biotechnology Stocks Vaccine Development Eli Lilly Kenvue Karuna Therapeutics Shares Vaccine Manufacturers

Structure’s Oral Obesity Pill Delivers 16.3% Placebo-Adjusted Weight Loss in Phase 2

The company set an FDA end-of-Phase-2 meeting for Q2 2026 ahead of a planned Phase 3 start in the second half of the year.

Lilly Combo of Zepbound and Taltz Tops Taltz Alone in Late-Stage Psoriasis Trials

Alumis TYK2 Pill Hits Phase 3 Goals in Psoriasis as Stock Jumps and $175 Million Offering Is Planned

Bristol Myers and J&J Halt Milvexian Heart-Attack Trial After Futility Finding

Moonlake Shares Plunge on Mixed Phase 3 Results for Hidradenitis Drug